Moderna will begin its late-stage trial by testing a possible vaccine to prevent Covid-19 on July 27, according to a publication published Tuesday on ClinicalTrials.gov.
© Provided by CNBC
A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against coronavirus disease (COVID-19), in Cambridge, Massachusetts, May 18, 2020.
The test will enroll 30,000 participants, according to the website.
Moderna’s experimental vaccine contains genetic material called messenger RNA or mRNA. MRNA is a genetic code that tells cells what to build, in this case, an antigen that can induce an immune response to the virus. She became the first candidate to participate in a phase one human trial in March.
This is a developing story. Please check for updates.
Video: Drug maker says antiviral can reduce deaths in severely ill coronavirus (MSNBC) patients
UNTIL NEXT TIME
Keep reading
